Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
Cardenal F, Arnaiz MD, Morán T, Jové J, Nadal E, Porta R, Solé JM, Brao I, Palmero R, Fuentes R, Núñez I, Caveda E, Cassinello A. Cardenal F, et al. Among authors: jove j. Lung Cancer. 2011 Oct;74(1):69-74. doi: 10.1016/j.lungcan.2011.01.021. Epub 2011 Feb 24. Lung Cancer. 2011. PMID: 21353323 Clinical Trial.
Lung Cancer OncoGuia.
Lung Cancer OncoGuia Group; Manchon Walsh P, Manchon P, Borràs JM, Ferro T, Espinàs JA. Lung Cancer OncoGuia Group, et al. Clin Transl Oncol. 2009 Dec;11(12):805-24. doi: 10.1007/s12094-009-0449-0. Clin Transl Oncol. 2009. PMID: 20045787 Review. No abstract available.
Cognitive and brain structural changes in a lung cancer population.
Simó M, Root JC, Vaquero L, Ripollés P, Jové J, Ahles T, Navarro A, Cardenal F, Bruna J, Rodríguez-Fornells A. Simó M, et al. Among authors: jove j. J Thorac Oncol. 2015 Jan;10(1):38-45. doi: 10.1097/JTO.0000000000000345. J Thorac Oncol. 2015. PMID: 25325778 Free PMC article.
Brain functional connectivity in lung cancer population: an exploratory study.
Simó M, Rifà-Ros X, Vaquero L, Ripollés P, Cayuela N, Jové J, Navarro A, Cardenal F, Bruna J, Rodríguez-Fornells A. Simó M, et al. Among authors: jove j. Brain Imaging Behav. 2018 Apr;12(2):369-382. doi: 10.1007/s11682-017-9697-8. Brain Imaging Behav. 2018. PMID: 28290076
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
Bonet M, González D, Baquedano JE, García E, Altabas M, Casas F, Feltes N, Ferrer F, Foro P, Fuentes R, Galdeano M, Gomez D, Henriquez I, Jové J, Lozano J, Maldonado X, Mases J, Membrive I, Paredes S, Roselló À, Sancho G, Mira M. Bonet M, et al. Among authors: jove j. Clin Transl Oncol. 2023 Apr;25(4):1017-1023. doi: 10.1007/s12094-022-03005-4. Epub 2022 Nov 27. Clin Transl Oncol. 2023. PMID: 36436177
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.
López-Torrecilla J, Boladeras A, Cabeza MA, Zapatero A, Jove J, Esteban LM, Henriquez I, Casaña M, González-San Segundo C, Gómez-Caamaño A, Mengual JL, Hervás A, Muñoz JL, Sanz G. López-Torrecilla J, et al. Among authors: jove j. Strahlenther Onkol. 2015 Oct;191(10):792-800. doi: 10.1007/s00066-015-0866-7. Epub 2015 Jul 9. Strahlenther Onkol. 2015. PMID: 26156249
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort.
Gomez-Iturriaga A, Cabeza Á, Pastor J, Jove J, Casaña M, Caamaño AG, Mengual J, Henríquez I, Muñoz J, Hervás A, Segundo CG. Gomez-Iturriaga A, et al. Among authors: jove j. Clin Transl Oncol. 2016 Oct;18(10):1026-33. doi: 10.1007/s12094-016-1481-5. Epub 2016 Jan 19. Clin Transl Oncol. 2016. PMID: 26781470
74 results